1 |
Sassa N, Yokoyama Y, Nishida Y, et al. Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departments[J].Int J Clin Oncol, 2020, 25(5):929-936.
|
2 |
辛星,夏志军,宋悦. 原发性盆腔腹膜后肿瘤的诊治进展[J]. 国际妇产科学杂志,2013, 40(2):160-163.
|
3 |
徐晓钢,曾纪晓,刘斐等.经脐单孔3D腹腔镜手术治疗小儿先天性胆总管囊肿[J/CD].中华腔镜外科杂志(电子版),2021,14(03):172-176.
|
4 |
徐敬云,杨鑫,丁波等.单孔腹腔镜腹股沟淋巴结清扫术在原发性阴道癌中的应用[J/CD].中华腔镜外科杂志(电子版),2018,11(05):281-285.
|
5 |
Goyal G, Young JR, Koster MJ, et al. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: erdheim-chester disease, langerhans cell histiocytosis, and rosai-dorfman disease[J].Mayo Clin Proc, 2019, 94(10):2054-2071.
|
6 |
Nathan B, Roomallah B, Salisbury JR, et al. A rare cause of lymphadenopathy - Rosai-Dorfman disease in a HIV-positive Ugandan woman[J].Int J STD AIDS, 2016, 27(12):1123-1125.
|
7 |
Yao JD, McCullough AE, Walker RC, et al. Brucellosis and sinus histiocytosis with massive lymphadenopathy[J].Am J Med, 1989, 86(1):111-114.
|
8 |
Luppi M, Barozzi P, Garber R, et al. Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases[J].Am J Pathol, 1998, 153(3):815-823.
|
9 |
Richardson TE, Wachsmann M, Oliver D, et al. BRAF mutation leading to central nervous system rosai-dorfman disease[J].Ann Neurol, 2018, 84(1):147-152.
|
10 |
Morgan NV, Morris MR, Cangul H, et al. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease[J].PLoS Genet, 2010, 6(2):e1000833.
|
11 |
Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity[J].Semin Diagn Pathol, 1990, 7(1):19-73.
|
12 |
Bruce-Brand C, Schneider JW, Schubert P. Rosai-Dorfman disease: an overview[J].J Clin Pathol, 2020, 73(11):697-705.
|
13 |
Abla O, Jacobsen E, Picarsic J, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease[J].Blood, 2018, 131(26):2877-2890.
|
14 |
Sodhi KS, Suri S, Nijhawan R, et al. Rosai-Dorfman disease: unusual cause of diffuse and massive retroperitoneal lymphadenopathy[J].Br J Radiol, 2005, 78(933):845-847.
|
15 |
Lauwers GY, Perez-Atayde A, Dorfman RF, et al. The digestive system manifestations of Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy): review of 11 cases[J].Hum Pathol, 2000, 31(3):380-385.
|
16 |
Murray J, Fox H. Rosai-Dorfman disease of the uterine cervix[J].Int J Gynecol Pathol, 1991, 10(2):209-213.
|
17 |
Pulsoni A, Anghel G, Falcucci P, et al. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review[J].Am J Hematol, 2002, 69(1):67-71.
|
18 |
Lima FB, Barcelos PS, Constancio AP, et al. Rosai-Dorfman disease with spontaneous resolution: case report of a child[J].Rev Bras Hematol Hemoter, 2011, 33(4):312-314.
|
19 |
陆立彦,琚梧桐,蔡鸣,等.颌面部皮肤型Rosai-Dorfman病复发病例1例报告及文献复习[J]. 中国口腔颌面外科杂志,2013, 11(1):85-88.
|
20 |
Serio G, Tenchini P, Nifosi F, et al. Surgical strategy in primary retroperitoneal tumours[J].Br J Surg.,1989, 76(4):385-389.
|
21 |
Zhang D, Sun Y, Lian L, et al. Long-term surgical outcomes after resection of presacral tumours and risk factors associated with recurrence[J].Colorectal Dis, 2021, 23(9):2301-2310.
|